Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Opioid Blister-Pack Mandate Tops Gottlieb's Agenda With New Authority

Executive Summary

US FDA Commissioner says mandate for unit-of-dose packaging for opioids coming soon, but also acknowledges that move may make the drugs more expensive.
Advertisement

Related Content

Opioid Blister Pack Mandate Could Be Phased-In Based On Prescription Volume
Gottlieb Leaves FDA Feeling Good About Generic Approvals, But Concerned About Innovative Competition
DTC Advertising: The 'Kick Me' Sign On Big Pharma’s Backs
PhRMA’s Defensive Move On DTC Ads: Putting Drug List Prices ‘In Context’
US FDA Sets Generic Approval Record, But Generic Sponsors Aren't Celebrating
Opioid Prescribing Guidelines Put US FDA In Unfamiliar Territory
Opioid Approvals: Congress Wants US FDA Guidance On Abuse Potential
Opioid REMS Increases Nearly Six-Fold As US FDA Adds Immediate-Release Products
US FDA Chief Gottlieb Envisions Tiered Mandates For Opioid Training System
Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling

Topics

Advertisement
UsernamePublicRestriction

Register

PS124104

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel